Companies 0 See All
Hedge Funds 0 See All
Insiders 0 See All
Institutional Investors 0 See All
Click here to see all results for
Home > Insider Trading > Bioxcel Therapeutics Inc. > Hedge Fund Holdings

Bioxcel Therapeutics Inc. (BTAI)

Market is closed
Hedge Fund Holdings
Filing Period:
Last update:
No. Hedge Fund Shares Value Activity % Port
1.
Oaktree Capital Management

Howard Marks

 241,188 $436,551 0.01%
2.
Citadel Investment Group

Ken Griffin

 11,378 $20,594 0%
Insider Monkey Quarterly Strategy
+373.4% Insider Monkey Quarterly Strategy
+154.9% Benchmark50% S&P 500 ETF and 50% Russell 2000 ETF
300%
200%
100%
Subscribe Now

Returns since its inception in May 2014 (through February 19th, 2025)